nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—MAOB—Alzheimer's disease	0.751	1	CbGaD
Nandrolone decanoate—Hypertrophy—Donepezil—Alzheimer's disease	0.0238	0.237	CcSEcCtD
Nandrolone decanoate—MAOA—locus ceruleus—Alzheimer's disease	0.0118	0.312	CbGeAlD
Nandrolone decanoate—Benign prostatic hyperplasia—Rivastigmine—Alzheimer's disease	0.0115	0.114	CcSEcCtD
Nandrolone decanoate—Furunculosis—Rivastigmine—Alzheimer's disease	0.00469	0.0466	CcSEcCtD
Nandrolone decanoate—Furuncle—Rivastigmine—Alzheimer's disease	0.00407	0.0404	CcSEcCtD
Nandrolone decanoate—Hirsutism—Donepezil—Alzheimer's disease	0.00386	0.0384	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Donepezil—Alzheimer's disease	0.00311	0.031	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Rivastigmine—Alzheimer's disease	0.00293	0.0291	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Memantine—Alzheimer's disease	0.00283	0.0281	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Rivastigmine—Alzheimer's disease	0.00277	0.0275	CcSEcCtD
Nandrolone decanoate—Dysphonia—Rivastigmine—Alzheimer's disease	0.00242	0.0241	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00209	0.0207	CcSEcCtD
Nandrolone decanoate—MAOB—embryo—Alzheimer's disease	0.00194	0.0512	CbGeAlD
Nandrolone decanoate—Fluid retention—Rivastigmine—Alzheimer's disease	0.00189	0.0188	CcSEcCtD
Nandrolone decanoate—CYP19A1—forebrain—Alzheimer's disease	0.00182	0.0482	CbGeAlD
Nandrolone decanoate—Libido decreased—Donepezil—Alzheimer's disease	0.00176	0.0175	CcSEcCtD
Nandrolone decanoate—MAOB—forebrain—Alzheimer's disease	0.00171	0.0453	CbGeAlD
Nandrolone decanoate—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00169	0.0168	CcSEcCtD
Nandrolone decanoate—MAOA—embryo—Alzheimer's disease	0.00165	0.0437	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00162	0.0161	CcSEcCtD
Nandrolone decanoate—AR—forebrain—Alzheimer's disease	0.00161	0.0426	CbGeAlD
Nandrolone decanoate—Libido decreased—Memantine—Alzheimer's disease	0.0016	0.0159	CcSEcCtD
Nandrolone decanoate—MAOB—telencephalon—Alzheimer's disease	0.00158	0.0417	CbGeAlD
Nandrolone decanoate—Libido decreased—Rivastigmine—Alzheimer's disease	0.00156	0.0155	CcSEcCtD
Nandrolone decanoate—Irritability—Donepezil—Alzheimer's disease	0.00156	0.0155	CcSEcCtD
Nandrolone decanoate—AR—telencephalon—Alzheimer's disease	0.00148	0.0392	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00147	0.0146	CcSEcCtD
Nandrolone decanoate—MAOA—forebrain—Alzheimer's disease	0.00146	0.0387	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00144	0.0143	CcSEcCtD
Nandrolone decanoate—Irritability—Memantine—Alzheimer's disease	0.00141	0.014	CcSEcCtD
Nandrolone decanoate—MAOA—telencephalon—Alzheimer's disease	0.00135	0.0356	CbGeAlD
Nandrolone decanoate—Jaundice—Donepezil—Alzheimer's disease	0.00122	0.0122	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Memantine—Alzheimer's disease	0.00118	0.0117	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00115	0.0115	CcSEcCtD
Nandrolone decanoate—Hypertension—Galantamine—Alzheimer's disease	0.00109	0.0109	CcSEcCtD
Nandrolone decanoate—CYP19A1—nervous system—Alzheimer's disease	0.000989	0.0261	CbGeAlD
Nandrolone decanoate—CYP19A1—central nervous system—Alzheimer's disease	0.000952	0.0252	CbGeAlD
Nandrolone decanoate—Ethynodiol—ESR1—Alzheimer's disease	0.000945	0.286	CrCbGaD
Nandrolone decanoate—MAOB—nervous system—Alzheimer's disease	0.000931	0.0246	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Memantine—Alzheimer's disease	0.000923	0.00917	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000903	0.00897	CcSEcCtD
Nandrolone decanoate—MAOB—central nervous system—Alzheimer's disease	0.000896	0.0237	CbGeAlD
Nandrolone decanoate—MAOB—cerebellum—Alzheimer's disease	0.000876	0.0232	CbGeAlD
Nandrolone decanoate—AR—nervous system—Alzheimer's disease	0.000876	0.0231	CbGeAlD
Nandrolone decanoate—Hypertension—Donepezil—Alzheimer's disease	0.000847	0.00843	CcSEcCtD
Nandrolone decanoate—AR—central nervous system—Alzheimer's disease	0.000843	0.0223	CbGeAlD
Nandrolone decanoate—Norgestimate—ESR1—Alzheimer's disease	0.000804	0.243	CrCbGaD
Nandrolone decanoate—Oedema—Donepezil—Alzheimer's disease	0.000801	0.00797	CcSEcCtD
Nandrolone decanoate—MAOA—nervous system—Alzheimer's disease	0.000794	0.021	CbGeAlD
Nandrolone decanoate—Hypertension—Memantine—Alzheimer's disease	0.000769	0.00765	CcSEcCtD
Nandrolone decanoate—MAOA—central nervous system—Alzheimer's disease	0.000765	0.0202	CbGeAlD
Nandrolone decanoate—CYP19A1—brain—Alzheimer's disease	0.000756	0.02	CbGeAlD
Nandrolone decanoate—Hypertension—Rivastigmine—Alzheimer's disease	0.000753	0.00748	CcSEcCtD
Nandrolone decanoate—MAOA—cerebellum—Alzheimer's disease	0.000747	0.0198	CbGeAlD
Nandrolone decanoate—Oedema—Memantine—Alzheimer's disease	0.000727	0.00723	CcSEcCtD
Nandrolone decanoate—MAOB—brain—Alzheimer's disease	0.000712	0.0188	CbGeAlD
Nandrolone decanoate—Oedema—Rivastigmine—Alzheimer's disease	0.000711	0.00707	CcSEcCtD
Nandrolone decanoate—Etonogestrel—ESR1—Alzheimer's disease	0.000695	0.21	CrCbGaD
Nandrolone decanoate—AR—brain—Alzheimer's disease	0.000669	0.0177	CbGeAlD
Nandrolone decanoate—Rash—Galantamine—Alzheimer's disease	0.000652	0.00648	CcSEcCtD
Nandrolone decanoate—Dermatitis—Galantamine—Alzheimer's disease	0.000651	0.00647	CcSEcCtD
Nandrolone decanoate—Urticaria—Donepezil—Alzheimer's disease	0.000636	0.00633	CcSEcCtD
Nandrolone decanoate—Nausea—Galantamine—Alzheimer's disease	0.000614	0.0061	CcSEcCtD
Nandrolone decanoate—MAOA—brain—Alzheimer's disease	0.000607	0.016	CbGeAlD
Nandrolone decanoate—Urticaria—Memantine—Alzheimer's disease	0.000578	0.00575	CcSEcCtD
Nandrolone decanoate—Pruritus—Donepezil—Alzheimer's disease	0.000567	0.00564	CcSEcCtD
Nandrolone decanoate—Urticaria—Rivastigmine—Alzheimer's disease	0.000565	0.00562	CcSEcCtD
Nandrolone decanoate—Pruritus—Memantine—Alzheimer's disease	0.000515	0.00512	CcSEcCtD
Nandrolone decanoate—Rash—Donepezil—Alzheimer's disease	0.000505	0.00502	CcSEcCtD
Nandrolone decanoate—Dermatitis—Donepezil—Alzheimer's disease	0.000505	0.00502	CcSEcCtD
Nandrolone decanoate—Pruritus—Rivastigmine—Alzheimer's disease	0.000503	0.00501	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—ESR1—Alzheimer's disease	0.000492	0.149	CrCbGaD
Nandrolone decanoate—Nausea—Donepezil—Alzheimer's disease	0.000476	0.00473	CcSEcCtD
Nandrolone decanoate—Rash—Memantine—Alzheimer's disease	0.000459	0.00456	CcSEcCtD
Nandrolone decanoate—Dermatitis—Memantine—Alzheimer's disease	0.000458	0.00456	CcSEcCtD
Nandrolone decanoate—Rash—Rivastigmine—Alzheimer's disease	0.000449	0.00446	CcSEcCtD
Nandrolone decanoate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000448	0.00446	CcSEcCtD
Nandrolone decanoate—Nausea—Memantine—Alzheimer's disease	0.000432	0.0043	CcSEcCtD
Nandrolone decanoate—Nausea—Rivastigmine—Alzheimer's disease	0.000423	0.0042	CcSEcCtD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000274	0.00255	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000272	0.00253	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000269	0.0025	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000267	0.00248	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000262	0.00244	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000261	0.00243	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000257	0.00239	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—MAOB—Alzheimer's disease	0.000252	0.00234	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000247	0.00229	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—MAOB—Alzheimer's disease	0.000246	0.00228	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000244	0.00227	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00024	0.00223	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000238	0.00222	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000237	0.0022	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000233	0.00217	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000233	0.00217	CbGpPWpGaD
Nandrolone decanoate—Progesterone—ESR1—Alzheimer's disease	0.000232	0.0703	CrCbGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000231	0.00215	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000229	0.00213	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000227	0.00211	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000223	0.00208	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000223	0.00208	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000218	0.00202	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000216	0.00201	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000215	0.002	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000212	0.00197	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000211	0.00196	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CHRNA7—Alzheimer's disease	0.00021	0.00195	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—GRIK1—Alzheimer's disease	0.00021	0.00195	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000208	0.00193	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.000203	0.00189	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000202	0.00188	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000197	0.00183	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000197	0.00183	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000197	0.00183	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000195	0.00182	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—PTGS1—Alzheimer's disease	0.000191	0.00177	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00019	0.00177	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000188	0.00175	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP2D6—Alzheimer's disease	0.000187	0.00174	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—PTGS1—Alzheimer's disease	0.000186	0.00173	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000185	0.00172	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000183	0.0017	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000181	0.00169	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000181	0.00168	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.00018	0.00167	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000178	0.00166	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—GRIK2—Alzheimer's disease	0.000178	0.00166	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CHAT—Alzheimer's disease	0.000178	0.00166	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.000178	0.00165	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.000176	0.00164	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—DHCR24—Alzheimer's disease	0.000172	0.0016	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000171	0.00159	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000171	0.00159	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000167	0.00155	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.000164	0.00153	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00016	0.00149	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000159	0.00148	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—GRIA1—Alzheimer's disease	0.000159	0.00148	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000158	0.00147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AKT1—Alzheimer's disease	0.000158	0.00147	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000157	0.00146	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000155	0.00144	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000154	0.00143	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000151	0.00141	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CHRNB2—Alzheimer's disease	0.000151	0.0014	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.00015	0.0014	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000148	0.00138	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000148	0.00137	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000147	0.00137	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA4—Alzheimer's disease	0.000147	0.00136	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000142	0.00132	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000141	0.00131	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000141	0.00131	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—ACHE—Alzheimer's disease	0.000138	0.00129	CbGpPWpGaD
Nandrolone decanoate—Progesterone—CYP2D6—Alzheimer's disease	0.000138	0.0418	CrCbGaD
Nandrolone decanoate—MAOB—Metabolism—GAPDHS—Alzheimer's disease	0.000138	0.00128	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000137	0.00127	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CHRNA4—Alzheimer's disease	0.000137	0.00127	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000136	0.00127	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PHF1—Alzheimer's disease	0.000134	0.00125	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000132	0.00123	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ATP5A1—Alzheimer's disease	0.000131	0.00122	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00013	0.00121	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000128	0.00119	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PLD3—Alzheimer's disease	0.000125	0.00116	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000124	0.00115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BCHE—Alzheimer's disease	0.000121	0.00112	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HSD17B10—Alzheimer's disease	0.00012	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—DLG4—Alzheimer's disease	0.000118	0.00109	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000115	0.00107	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP46A1—Alzheimer's disease	0.000115	0.00107	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—GRIN2B—Alzheimer's disease	0.000115	0.00107	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—PLCB1—Alzheimer's disease	0.000114	0.00106	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000112	0.00105	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ND1—Alzheimer's disease	0.000111	0.00103	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.00011	0.00103	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.00011	0.00102	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—DHCR24—Alzheimer's disease	0.000108	0.00101	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000106	0.000988	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—DHCR24—Alzheimer's disease	0.000106	0.000981	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	9.93e-05	0.000923	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	9.92e-05	0.000922	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	9.84e-05	0.000915	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	9.69e-05	0.000901	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	9.56e-05	0.000889	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	9.55e-05	0.000888	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	9.5e-05	0.000883	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA4—Alzheimer's disease	9.2e-05	0.000855	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	9.2e-05	0.000855	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA4—Alzheimer's disease	8.97e-05	0.000834	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	8.77e-05	0.000815	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GAPDHS—Alzheimer's disease	8.65e-05	0.000804	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TFAM—Alzheimer's disease	8.64e-05	0.000804	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	8.54e-05	0.000794	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GAPDHS—Alzheimer's disease	8.44e-05	0.000784	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—PRKCG—Alzheimer's disease	8.41e-05	0.000782	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	8.34e-05	0.000776	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	8.34e-05	0.000775	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	8.32e-05	0.000774	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ATP5A1—Alzheimer's disease	8.2e-05	0.000762	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.13e-05	0.000756	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	8.03e-05	0.000746	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ATP5A1—Alzheimer's disease	8e-05	0.000744	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PLD3—Alzheimer's disease	7.82e-05	0.000727	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PLD3—Alzheimer's disease	7.63e-05	0.000709	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	7.63e-05	0.000709	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	7.62e-05	0.000709	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	7.61e-05	0.000708	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.54e-05	0.000701	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSD17B10—Alzheimer's disease	7.5e-05	0.000697	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	7.36e-05	0.000684	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	7.35e-05	0.000683	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	7.34e-05	0.000683	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	7.31e-05	0.00068	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CALM1—Alzheimer's disease	7.28e-05	0.000676	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	7.25e-05	0.000674	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP46A1—Alzheimer's disease	7.22e-05	0.000671	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CHAT—Alzheimer's disease	7.16e-05	0.000666	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TPI1—Alzheimer's disease	7.16e-05	0.000666	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.15e-05	0.000665	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	7.08e-05	0.000658	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	7.06e-05	0.000657	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	7.06e-05	0.000656	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	7.04e-05	0.000655	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ND1—Alzheimer's disease	6.97e-05	0.000648	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ND1—Alzheimer's disease	6.8e-05	0.000632	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.65e-05	0.000618	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GAPDH—Alzheimer's disease	6.61e-05	0.000614	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	6.51e-05	0.000605	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—A2M—Alzheimer's disease	6.38e-05	0.000593	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	6.24e-05	0.00058	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	6.23e-05	0.000579	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CREB1—Alzheimer's disease	6.23e-05	0.000579	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.08e-05	0.000565	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.05e-05	0.000563	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	6.01e-05	0.000558	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACHE—Alzheimer's disease	5.55e-05	0.000516	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	5.51e-05	0.000513	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—INPP5D—Alzheimer's disease	5.49e-05	0.00051	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	5.48e-05	0.000509	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	5.34e-05	0.000496	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	5.28e-05	0.000491	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.24e-05	0.000487	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF2S1—Alzheimer's disease	5.2e-05	0.000484	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS1—Alzheimer's disease	5.2e-05	0.000484	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO1—Alzheimer's disease	5.2e-05	0.000484	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	5.15e-05	0.000479	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2D6—Alzheimer's disease	5.1e-05	0.000474	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	5.1e-05	0.000474	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.88e-05	0.000454	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—Alzheimer's disease	4.84e-05	0.00045	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	4.81e-05	0.000448	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.77e-05	0.000444	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	4.71e-05	0.000438	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	4.62e-05	0.00043	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PLCB1—Alzheimer's disease	4.56e-05	0.000424	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.54e-05	0.000422	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CHAT—Alzheimer's disease	4.49e-05	0.000418	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TPI1—Alzheimer's disease	4.49e-05	0.000418	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCA1—Alzheimer's disease	4.42e-05	0.000411	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TPI1—Alzheimer's disease	4.38e-05	0.000407	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CHAT—Alzheimer's disease	4.38e-05	0.000407	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.31e-05	0.000401	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MAOB—Alzheimer's disease	4.31e-05	0.0004	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MAOB—Alzheimer's disease	4.2e-05	0.000391	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GAPDH—Alzheimer's disease	4.15e-05	0.000386	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	4.04e-05	0.000376	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—A2M—Alzheimer's disease	4e-05	0.000372	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4e-05	0.000372	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.98e-05	0.00037	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.96e-05	0.000368	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—A2M—Alzheimer's disease	3.91e-05	0.000363	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.83e-05	0.000356	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARGC1A—Alzheimer's disease	3.81e-05	0.000354	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HMOX1—Alzheimer's disease	3.8e-05	0.000353	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACHE—Alzheimer's disease	3.48e-05	0.000324	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.48e-05	0.000324	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—LPL—Alzheimer's disease	3.47e-05	0.000323	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—INPP5D—Alzheimer's disease	3.44e-05	0.00032	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACHE—Alzheimer's disease	3.4e-05	0.000316	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	3.36e-05	0.000312	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS1—Alzheimer's disease	3.26e-05	0.000304	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO1—Alzheimer's disease	3.26e-05	0.000304	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2D6—Alzheimer's disease	3.2e-05	0.000298	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO1—Alzheimer's disease	3.18e-05	0.000296	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	3.18e-05	0.000296	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—Alzheimer's disease	3.13e-05	0.000291	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	3.12e-05	0.00029	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—Alzheimer's disease	3.03e-05	0.000282	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—Alzheimer's disease	2.96e-05	0.000275	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CALM1—Alzheimer's disease	2.92e-05	0.000271	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APOE—Alzheimer's disease	2.91e-05	0.000271	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAV1—Alzheimer's disease	2.88e-05	0.000268	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PLCB1—Alzheimer's disease	2.86e-05	0.000266	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	2.79e-05	0.00026	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCA1—Alzheimer's disease	2.78e-05	0.000258	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.74e-05	0.000255	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	2.71e-05	0.000252	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—Alzheimer's disease	2.54e-05	0.000236	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARG—Alzheimer's disease	2.53e-05	0.000236	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—INS—Alzheimer's disease	2.49e-05	0.000231	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH1—Alzheimer's disease	2.46e-05	0.000228	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	2.39e-05	0.000222	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HMOX1—Alzheimer's disease	2.38e-05	0.000221	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	2.33e-05	0.000217	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	2.32e-05	0.000216	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPARG—Alzheimer's disease	2.32e-05	0.000216	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NOS3—Alzheimer's disease	2.18e-05	0.000203	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—LPL—Alzheimer's disease	2.18e-05	0.000203	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—LPL—Alzheimer's disease	2.12e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—Alzheimer's disease	1.99e-05	0.000185	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—Alzheimer's disease	1.96e-05	0.000182	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.91e-05	0.000178	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CALM1—Alzheimer's disease	1.83e-05	0.00017	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APOE—Alzheimer's disease	1.83e-05	0.00017	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAV1—Alzheimer's disease	1.81e-05	0.000168	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.79e-05	0.000166	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.78e-05	0.000166	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.76e-05	0.000164	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARG—Alzheimer's disease	1.59e-05	0.000148	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—INS—Alzheimer's disease	1.56e-05	0.000145	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARG—Alzheimer's disease	1.55e-05	0.000144	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—INS—Alzheimer's disease	1.52e-05	0.000141	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NOS3—Alzheimer's disease	1.37e-05	0.000127	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NOS3—Alzheimer's disease	1.33e-05	0.000124	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—Alzheimer's disease	1.25e-05	0.000116	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	1.22e-05	0.000113	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—Alzheimer's disease	1e-05	9.32e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—Alzheimer's disease	9.17e-06	8.52e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—Alzheimer's disease	6.29e-06	5.85e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—Alzheimer's disease	6.13e-06	5.7e-05	CbGpPWpGaD
